Myocor Inc.

CSI will sidestep IPO, merge with public start-up; With equity offerings scarce, the New Brighton med-tech firm will acquire Replidyne for its cash and ticker symbol.(BUSINESS)
Star Tribune (Minneapolis, MN); 11/5/2008; 1118 words; ...acquiring the remaining assets of Replidyne Inc. of Colorado. Replidyne is essentially...will be called Cardiovascular Systems Inc. and trade under the ticker symbol...option. Last week, cash-strapped Myocor Inc. of Maple Grove shut down its operations...

Myocor, Inc. Implants First iCoapsys Device.
Business Wire; 5/13/2008; 1018 words; MAPLE GROVE, Minn. -- Myocor, Inc. announced that its percutaneous iCoapsys...May 7, 2008. iCoapsys is one of two Myocor devices designed to treat patients...the Mitral Valve) clinical trial. Myocor CEO Jim Hickey said, "This first...

business people; TODAY'S SPOTLIGHT: CHRISTINE FRUECHTE.(BUSINESS INSIDER)
Star Tribune (Minneapolis, MN); 3/31/2008; 1103 words; ...BLANCHETTE AT THE TOP Gamer Packaging Inc., Minneapolis, promoted Ronald Gamer...1987 and is its first CEO. MOVING UP Myocor Inc., Maple Grove, promoted Scott Poellinger...Sloan, LaCrche Early Childhood Center Inc., was reappointed. The University...

Myocor Receives Approval for Percutaneous Trial.
PR Newswire; 12/5/2007; 856 words; ...MAPLE GROVE, Minn., Dec. 5 /PRNewswire/ -- Myocor, Inc. announced that the U.S. Food and Drug Administration...507-664-0482, jennings@neuger.com, for Myocor, Inc.; or for Myocor, Inc., 1-888-761-3400

Minnesota Inventors Develop Heart Valve Treatment Method
US Fed News Service, Including US State News; 7/25/2007; 490 words; ...regurgitation." The inventors were issued U.S. Patent No. 7,247,134 on July 24. The patent has been assigned to Myocor Inc., Maple Grove. The original application was filed on Nov. 10, 2003, and is available at: http://patft.uspto...